FIA
DMK

FNY Investment Advisers’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

FNY Investment Advisers’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-11
Closed -$2K – 1369
2018
Q2 		$2K Buy
+11
New +$2.95K ﹤0.01% 857

Other funds holding DMK

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FNY Investment Advisers's DMK Position: Q3 2018 in Review

FNY Investment Advisers sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2018, closing a stake of 11 shares — an estimated $2K sold.

FNY Investment Advisers first reported a position in DMK in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 57 funds tracked by Wall St. Rank hold DMK as of Q3 2018.

  • FNY Investment Advisers reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2018 after selling out during the quarter.
  • FNY Investment Advisers sold 11 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2018, an estimated $2K.
  • FNY Investment Advisers first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2018 and held it in 1 quarter.
  • FNY Investment Advisers's DMK Pharmaceuticals Corporation Common Stock position peaked at $2K in Q2 2018.
  • 57 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2018.

Based on FNY Investment Advisers's 13F filing for Q3 2018, filed 29 Oct 2018.